HLM Venture Partners

We’re excited to announce that NeuroFlow has acquired Owl, the leading measurement-based care company for behavioral health providers and health plans. This deal creates the largest end-to-end platform for identifying and managing behavioral health needs across the entire healthcare continuum. By merging with Owl, NeuroFlow now offers the most expansive suite of solutions for delivering measurement-based and feedback-informed care. The platform supports health systems, health plans, the federal government, and now behavioral health providers. “Owl provides a comprehensive solution for monitoring patients who need a higher level of care, giving providers the tools to track and measure outcomes over time and ensure quality and consistency throughout the care journey,” says Christopher Molaro “This is just the beginning; we intend to build on this foundation to improve access and engagement.” Read the complete press release here: https://lnkd.in/ecN2kcxs #acquisition #behavioralhealth #mentalhealth #measurementbasedcare

Carevīve joins forces with Health Catalyst! Today marks a pivotal moment for Carevive, our patients, and our clients, as we unite with Health Catalyst, a leading provider of data and analytics technology, and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Carevive is excited to join forces with Health Catalyst. By uniting, we expand our capabilities and enhance our ability to make a difference towards amplifying the patient's voice in cancer care. “With their expertise and solutions augmenting ours, Carevive is poised to deliver even more innovative solutions to cancer centers and provide researchers with unparalleled real-world data. Together, we are shaping a future where patient-centered care and groundbreaking research converge seamlessly,” said Bruno Lempernesse, Carevive’s CEO. 💻 Read the press release here: https://lnkd.in/epWtfk3j #StrongerTogether #CorporateGrowth #GrowthStrategy #InnovateTogether #NewBeginnings #BusinessSuccess #CancerCare

Exciting News! Wayspring has secured a minority investment led by CVS Health Ventures to expand our innovative Substance Use Disorder (SUD) Home Program. This support will help us extend our comprehensive, value-based care model to more communities, addressing the critical need for advanced SUD treatment. Read our latest press release to learn more about this exciting development: